BSN set for blowout with tightened OID, Aussie dollar success

Strong demand from banks and funds has allowed bookrunners on the senior loans backing EQT’s buy-out of German bandages maker BSN Medical to tighten the yield on the term loan ‘B’ in the borrower’s favour and increase the size of the committed acquisition facility by €50m — taking the total amount of senior loans to €915m.

  • 13 Jul 2012
As a large, well performing company with an existing syndicate and in a strong sector and jurisdiction, BSN had long been expected to be a blowout. Some loan investors had expressed concern about BSN’s leverage when the deal was launched, saying syndication may not be so straightforward. But ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

GlobalCapital European securitization league table

Rank Lead Manager/Arranger Total Volume $m No. of Deals Share % by Volume
1 Bank of America Merrill Lynch (BAML) 1,284 2 30.09
2 Barclays 633 1 14.82
3 BNP Paribas 509 1 11.91
4 Citi 467 1 10.94
5 Morgan Stanley 455 1 10.66

Bookrunners of Global Structured Finance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Citi 12,356.92 41 13.22%
2 Bank of America Merrill Lynch 10,716.42 32 11.47%
3 Barclays 8,716.58 27 9.33%
4 JPMorgan 7,774.38 29 8.32%
5 Wells Fargo Securities 7,444.83 29 7.97%